VanEck Associates’s bluebird bio BLUE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q3
Sell
-3,321
Closed -$2.63M 1018
2020
Q2
$2.63M Buy
3,321
+1,397
+73% +$1.05M 0.01% 444
2020
Q1
$1.15M Buy
1,924
+96
+5% +$93.6K 0.01% 545
2019
Q4
$2.08M Buy
1,828
+189
+12% +$205K 0.01% 511
2019
Q3
$1.95M Sell
1,639
-64
-4% -$97.7K 0.01% 482
2019
Q2
$2.81M Sell
1,703
-1,110
-39% -$1.92M 0.01% 425
2019
Q1
$5.73M Sell
2,813
-1,045
-27% -$1.84M 0.03% 286
2018
Q4
$4.96M Sell
3,858
-219
-5% -$336K 0.02% 311
2018
Q3
$7.71M Buy
4,077
+1,368
+50% +$2.83M 0.04% 267
2018
Q2
$5.51M Buy
2,709
+282
+12% +$643K 0.03% 291
2018
Q1
$5.37M Sell
2,427
-475
-16% -$1.21M 0.03% 287
2017
Q4
$6.69M Sell
2,902
-1,415
-33% -$2.87M 0.03% 261
2017
Q3
$7.68M Buy
4,317
+849
+24% +$1.19M 0.04% 257
2017
Q2
$4.72M Sell
3,468
-718
-17% -$866K 0.03% 291
2017
Q1
$4.93M Buy
4,186
+1,133
+37% +$1.16M 0.02% 296
2016
Q4
$2.44M Sell
3,053
-272
-8% -$216K 0.01% 374
2016
Q3
$2.92M Sell
3,325
-474
-12% -$343K 0.01% 351
2016
Q2
$2.13M Sell
3,799
-1,966
-34% -$1.11M 0.01% 361
2016
Q1
$3.17M Sell
5,765
-366
-6% -$225K 0.02% 292
2015
Q4
$5.1M Buy
6,131
+1,440
+31% +$1.44M 0.04% 225
2015
Q3
$5.2M Buy
+4,691
New +$8.55M 0.04% 236

Other funds holding BLUE

VanEck Associates's BLUE Position: Q3 2020 in Review

VanEck Associates sold out of bluebird bio (BLUE) in Q3 2020, closing a stake of 3,321 shares — an estimated $2.63M sold.

VanEck Associates first reported a position in BLUE in Q3 2015 and held it in 20 quarters. The position peaked at $7.71M in Q3 2018. 275 funds tracked by Wall St. Rank hold BLUE as of Q3 2020.

  • VanEck Associates reported no remaining bluebird bio position as of Q3 2020 after selling out during the quarter.
  • VanEck Associates sold 3,321 bluebird bio shares in Q3 2020, an estimated $2.63M.
  • VanEck Associates first reported a position in bluebird bio in Q3 2015 and held it in 20 quarters.
  • VanEck Associates's bluebird bio position peaked at $7.71M in Q3 2018.
  • 275 funds tracked by Wall St. Rank held bluebird bio as of Q3 2020.

Based on VanEck Associates's 13F filing for Q3 2020, filed 12 Nov 2020.